Posted on Jun 4, 2020 | Comments Off on Do No Harm? Doctors Are Giving Out 9X As Many Hydroxychloroquine Prescriptions, And That Puts People Who Need It At Risk
The antimalarial drug chloroquine (analogue hydroxychloroquine) is also successfully used to treat lupus, rheumatoid arthritis, and autoimmune diseases said to have similar biological mechanisms as COVID-19 and, lacking any remedies besides what can be done for the flu, in March the U.S. Food and Drug Administration (FDA) granted emergency use authorization for those compounds as treatments.read...
read more
Posted on Jun 3, 2020 | Comments Off on Randomized Double-Blind Trial Of Hydroxychloroquine Finds It’s In The Placebo Range
A randomized, double-blind, placebo-controlled trial to test hydroxychloroquine as post-exposure prophylaxis found that it does not prevent illness. Enrollment began on March 17th, 2020. To be eligible, people had be enrolled within 3 days after confirmed exposure. 821 asymptomatic participants, 719 who had reported a high-risk exposure to a confirmed Covid-19 contact, were...
read more
Posted on Jun 3, 2020 | Comments Off on Business Insider Takes A Trip Down 2019 Chemophobia Lane
Thanks to COVID-19, the public has gotten a lot more skeptical about claims that chemicals, food, and medicine are corporate conspiracies created to replace natural products that worked just fine. Even more ridiculous has been the belief that millions and millions of people are dying from these newer products even though there are no bodies to be found.Science is back, and that may be why...
read more
Posted on Jun 2, 2020 | Comments Off on New Flu? Coronavirus Might Become Cause Of A Seasonal Illness
The flu kills over 600,000 people each year and in 2020 another virus exploded in public health circles for the third time in 17 years; coronavirus.SARS-CoV-2, which causes the COVID-19 disease, has killed nearly 400,000, and given the risk factors it is hard to say how many would have been killed by any respiratory disease, but one question is not philosophical: is this the new normal? read...
read more
